Latest Asx News

HITIQ Limited's March quarter saw a remarkable 223% jump in sales to $294k, driven by the nationwide rollout of its PROTEQT™ concussion management system and initial international sales. The company bolstered its governance and advisory ranks while managing funding to support its commercial push.

Far Northern Resources has confirmed significant extensions to its Bridge Creek gold resource following Phase 2 drilling, revealing new mineralisation zones and setting a structured five-step plan for 2026 development.

Alterity Therapeutics has secured FDA alignment on the chemistry and manufacturing controls for its ATH434 Phase 3 trial in Multiple System Atrophy, marking a pivotal regulatory milestone ahead of the planned mid-2026 End-of-Phase 2 meeting.

AdNeo (ASX:AD1) delivered its first positive operating cash flow quarter since its 2025 transformation, driven by strong revenue growth across all divisions and a growing $8m tender pipeline. The company advances its AI-first strategy while managing costs and acquisitions.

Sentinel Metals is poised to launch its maiden drilling campaign at the Columbia Gold-Silver Project in Montana, pending final regulatory approval. The company also bolsters its local engagement with a strategic executive hire and advances environmental studies.

Barton Gold Holdings has reported exceptional high-grade gold assays up to 170 g/t at its Challenger project and strong drilling progress at Tunkillia, underpinning an advancing feasibility study and a robust cash balance of $13.3 million.

Sunshine Metals reveals a robust Mining Study at its Liontown Project in Queensland, targeting shallow oxide gold with initial production of approximately 75,000 ounces of gold and 654,000 ounces of silver, generating an estimated net operating cashflow of $163 million. High-grade drilling results and a $202K government grant support ongoing exploration and development.

88 Energy has amended its Participation Agreement with Burgundy Xploration, extending funding milestones to align with Burgundy’s US IPO process while securing US$400,000 in near-term payments and enhanced lease security. The Franklin Bluffs-1H well spud is now expected in Q1 2027, slightly delayed but underpinned by strong capital commitment.

Generation Development Group’s subsidiary Generation Life Limited has swiftly contained a cyber incident involving unauthorised access through a third-party provider, with no evidence of impact on core systems or unauthorised transactions.

X2M Connect accelerated revenue growth in Q3 FY26 with a 67% increase, driven by strong demand in South Korea and new Australian smart community deals. The company’s capital raise and expanding customer base underpin its push into new markets despite ongoing cash burn.

Imricor Medical Systems updates its SEC Form 10 with minor SEC-driven revisions as it pushes forward with FDA clearances and clinical trials, reporting a $25.3 million net loss in 2025 amid early-stage commercialisation.

The FDA has removed the postmarketing cardiac repolarization study requirement for Clinuvel's SCENESSE®, reflecting confidence in its long-term safety profile. This marks a regulatory milestone for the only approved treatment for erythropoietic protoporphyria in the US.